Uni Bio Science Group, Ltd.

As of December 31, 2025, Uni Bio Science Group, Ltd. carries a market capitalization of 686.69M, placing it among publicly traded companies globally. Its enterprise value stands at 615.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Uni Bio Science Group, Ltd. has 5.97B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Uni Bio Science Group, Ltd. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Uni Bio Science Group, Ltd.'s stock has declined approximately 44.09% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.09.

As of December 31, 2025, Uni Bio Science Group, Ltd. holds 168.82M in cash and equivalents against 97.76M in total debt, resulting in a net debt position of -80.98M. Total book value stands at 413.25M, with working capital of 230.79M providing operational flexibility.

Uni Bio Science Group, Ltd.'s most recent stock split took place on September 2, 2013 with a 1:2 split ratio.